Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LT2011 who wrote (12350)	8/14/2013 3:34:23 PM
From: Mimbari	Respond to of 13111

I really don't know why. Those agreements are in place to satisfy auditors. They are not used yet nor does the company plan to use them. Maybe they changed who they deal with because LP is possibly ticked that it was not exercised. Really, I don't know. Each company has their own terms I imagine. But this isn't really about that at all. Your testing and probing me to understand the girth of my knowledge and whether or not I am someone to be taken seriously.

To: LT2011 who wrote (12350)	9/5/2013 8:24:41 PM
From: LT2011	Read Replies (2) \| Respond to of 13111

I just noticed that the 5 board members all received 50,000 shares as a stock option with an exercised price of .67. Once here where is Dr. Wachter's stock option? Is this how they treat their own people? Do we really believe that he gave up his seat at the big boy table to create an independent board and miss out on stock options? For those who care I'm already working on an exit strategy. If this stock is the real deal then I'll consider buying back in at a higher price. Till then this smells like rotten fish.